Astellas Pharma Names Senior VP

From DCAT Value Chain Insights (VCI)

By People On The Move posted 01-15-2015 10:39


Astellas Pharma Inc. has name Eric Terhaerdt as senior vice president of global development operations. Terhaerdt will be located at Astellas' Headquarters for the Americas in Northbrook, Illinois and will report to Bernie Zeiher, executive vice president, global development and therapeutic area head: immunology, infectious disease, transplantation and central nervous system and pain, with Astellas Pharma Global Development, Inc.

Mr. Terhaerdt will be responsible for establishing the global direction of the drug development operations of Astellas in the Netherlands and the US and will work closely with Japan Development Operations to ensure global operational effectiveness and efficiency. As a key direct report to the executive vice president of global development, he will play an instrumental role in defining development strategy and ensuring the effective and efficient development of the Astellas product portfolio.

Prior to joining Astellas, he spent more than 20 years with AstraZeneca, serving in a variety of global leadership roles with increasing responsibility, in the areas of clinical research, clinical development, clinical quality, strategy and performance and scientific and technical evaluations.

Source: Astellas Pharma


Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription